{"id":1008889,"date":"2026-10-09T08:51:02","date_gmt":"2026-10-09T12:51:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/"},"modified":"2026-10-09T08:51:02","modified_gmt":"2026-10-09T12:51:02","slug":"filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/","title":{"rendered":"Filana Therapeutics to Participate in the 2026 Maxim Growth Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">AUSTIN, Texas, Oct.  09, 2026  (GLOBE NEWSWIRE) &#8212; Filana Therapeutics, Inc. (NASDAQ: FLNA, &#8220;Filana Therapeutics&#8221;, the &#8220;Company&#8221;), a biotechnology company currently focused on developing therapies for the treatment of Tuberous Sclerosis Complex (TSC)-related epilepsy, today announced that the Company\u2019s management team will participate in the 2026 Maxim Growth Summit being held October 12-14, 2026 in New York.<\/p>\n<p align=\"left\">\n        <strong>2026 Maxim Growth Summit Conference Details: <\/strong>\n      <\/p>\n<p align=\"left\">\n        <strong>Format: One-on-one meetings<\/strong><br \/>\n        <br \/>\n        <strong>Date: October 12\u201314, 2026<\/strong><br \/>\n        <br \/>\n        <strong>Location: The Hard Rock Hotel NYC<\/strong>\n      <\/p>\n<p align=\"justify\">For more information and a complete agenda, please visit www.maximgrp.com\/2026-growth-summit.<\/p>\n<p>\n        <strong>About\u00a0Filana Therapeutics, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Filana Therapeutics, Inc.\u00a0(NASDAQ: FLNA), is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A.<\/p>\n<p>For more information, please visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DIgtOWN7nX1b3B_GX8X1RJoEJCMzgmu9wOrnw-giX4LlW9MezNqt6FR0x5W9wYHDRRGj2DgZq65Hz_Vv4qJmzjMGd4n9wnXLVZdTJ27lAms=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.FilanaTx.com<\/a><\/p>\n<p>\n        <strong>For More Information Contact:<\/strong><br \/>\n        <br \/>\n        <strong>Investors<\/strong><br \/>\n        <br \/>Mike Moyer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lunSYxWuUVYldIM6nri6tDLLQjJkxR3skNLp2eDSdY7PXiUpFY4rbdwes-EHzIdNtHm6dlDWYF_KlXYIEReURKerJB1NCD45rPyqzGbzX3fJNeJ13Cl5RgBtBY5neuE9DETXZUrrwB4KtuJJUKVPxbHfOmE7gm3AAYGtDlqMzyFQO3_7tQLDgW2JRcu25CN6KusdQ1JHEdfVXZYt_ISH__nbrv9F9kNfN8PpbPkdf-zVfOb2kAkIhCTfkmHn_1dnqjC3W6T9UX83zNXz-HF8764nk04EKlln3T63mfTKmUw=\" rel=\"nofollow\" target=\"_blank\">mmoyer@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>Company<\/strong><br \/>\n        <br \/>Eric Schoen, Chief Financial Officer<br \/>(512) 501-2450<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RaqwLY0RV926PuCXajj2C_RVBv3MpUpr2MH4azg6o5O6Hb6LgVXfGsKjbYuPz6VPfC-VMbMWnb-XGx84dLYYK_mmrLlpekxtr4Yd4KJX4q0=\" rel=\"nofollow\" target=\"_blank\">ESchoen@FilanaTx.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lF1ljK_1-THtMoQC-Y1eHJMl9FYmlWqP044MK0B-BXAjCFlcLWqciGwOVv-OituSnK98CC3G7BTkAoC_2bVHNQ==\" rel=\"nofollow\" target=\"_blank\">IR@FilanaTx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjYwMyM3ODg3MTYzIzIwMjc4MTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzRjODg1NWQtMzU5Mi00MjI1LTg0NDgtYTcxN2U2NDZhMTAwLTEwNDAxOTctMjAyNi0xMC0wOS1lbg==\/tiny\/Filana-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>AUSTIN, Texas, Oct. 09, 2026 (GLOBE NEWSWIRE) &#8212; Filana Therapeutics, Inc. (NASDAQ: FLNA, &#8220;Filana Therapeutics&#8221;, the &#8220;Company&#8221;), a biotechnology company currently focused on developing therapies for the treatment of Tuberous Sclerosis Complex (TSC)-related epilepsy, today announced that the Company\u2019s management team will participate in the 2026 Maxim Growth Summit being held October 12-14, 2026 in New York. 2026 Maxim Growth Summit Conference Details: Format: One-on-one meetings Date: October 12\u201314, 2026 Location: The Hard Rock Hotel NYC For more information and a complete agenda, please visit www.maximgrp.com\/2026-growth-summit. About\u00a0Filana Therapeutics, Inc. Filana Therapeutics, Inc.\u00a0(NASDAQ: FLNA), is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Filana Therapeutics to Participate in the 2026 Maxim Growth Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1008889","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Filana Therapeutics to Participate in the 2026 Maxim Growth Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Filana Therapeutics to Participate in the 2026 Maxim Growth Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, Texas, Oct. 09, 2026 (GLOBE NEWSWIRE) &#8212; Filana Therapeutics, Inc. (NASDAQ: FLNA, &#8220;Filana Therapeutics&#8221;, the &#8220;Company&#8221;), a biotechnology company currently focused on developing therapies for the treatment of Tuberous Sclerosis Complex (TSC)-related epilepsy, today announced that the Company\u2019s management team will participate in the 2026 Maxim Growth Summit being held October 12-14, 2026 in New York. 2026 Maxim Growth Summit Conference Details: Format: One-on-one meetings Date: October 12\u201314, 2026 Location: The Hard Rock Hotel NYC For more information and a complete agenda, please visit www.maximgrp.com\/2026-growth-summit. About\u00a0Filana Therapeutics, Inc. Filana Therapeutics, Inc.\u00a0(NASDAQ: FLNA), is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous &hellip; Continue reading &quot;Filana Therapeutics to Participate in the 2026 Maxim Growth Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-09T12:51:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjYwMyM3ODg3MTYzIzIwMjc4MTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Filana Therapeutics to Participate in the 2026 Maxim Growth Summit\",\"datePublished\":\"2026-10-09T12:51:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\\\/\"},\"wordCount\":177,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0MjYwMyM3ODg3MTYzIzIwMjc4MTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\\\/\",\"name\":\"Filana Therapeutics to Participate in the 2026 Maxim Growth Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0MjYwMyM3ODg3MTYzIzIwMjc4MTI=\",\"datePublished\":\"2026-10-09T12:51:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0MjYwMyM3ODg3MTYzIzIwMjc4MTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0MjYwMyM3ODg3MTYzIzIwMjc4MTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Filana Therapeutics to Participate in the 2026 Maxim Growth Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Filana Therapeutics to Participate in the 2026 Maxim Growth Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/","og_locale":"en_US","og_type":"article","og_title":"Filana Therapeutics to Participate in the 2026 Maxim Growth Summit - Market Newsdesk","og_description":"AUSTIN, Texas, Oct. 09, 2026 (GLOBE NEWSWIRE) &#8212; Filana Therapeutics, Inc. (NASDAQ: FLNA, &#8220;Filana Therapeutics&#8221;, the &#8220;Company&#8221;), a biotechnology company currently focused on developing therapies for the treatment of Tuberous Sclerosis Complex (TSC)-related epilepsy, today announced that the Company\u2019s management team will participate in the 2026 Maxim Growth Summit being held October 12-14, 2026 in New York. 2026 Maxim Growth Summit Conference Details: Format: One-on-one meetings Date: October 12\u201314, 2026 Location: The Hard Rock Hotel NYC For more information and a complete agenda, please visit www.maximgrp.com\/2026-growth-summit. About\u00a0Filana Therapeutics, Inc. Filana Therapeutics, Inc.\u00a0(NASDAQ: FLNA), is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous &hellip; Continue reading \"Filana Therapeutics to Participate in the 2026 Maxim Growth Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-09T12:51:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjYwMyM3ODg3MTYzIzIwMjc4MTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Filana Therapeutics to Participate in the 2026 Maxim Growth Summit","datePublished":"2026-10-09T12:51:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/"},"wordCount":177,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjYwMyM3ODg3MTYzIzIwMjc4MTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/","name":"Filana Therapeutics to Participate in the 2026 Maxim Growth Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjYwMyM3ODg3MTYzIzIwMjc4MTI=","datePublished":"2026-10-09T12:51:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjYwMyM3ODg3MTYzIzIwMjc4MTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0MjYwMyM3ODg3MTYzIzIwMjc4MTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/filana-therapeutics-to-participate-in-the-2026-maxim-growth-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Filana Therapeutics to Participate in the 2026 Maxim Growth Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1008889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1008889"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1008889\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1008889"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1008889"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1008889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}